CONTRAINDICATIONS
NUCALA should not be administered to patients with a history of hypersensitivity to mepolizumab or excipients in the formulation.

...CONTINUED BELOW

PERMANENT J-CODE FOR NUCALA
The permanent J-CODE (J2182) will apply to dates of service on or after January 1, 2017


Helping to meet the changing access needs of your patient

Today’s ever-changing healthcare environment may create challenges for your patients. Gateway to NUCALA offers resources and services to help meet the changing access needs of your patients.

Co-pay Assistance/Patient Assistance and Affordability

Gateway to NUCALA includes co-pay and patient assistance programs for eligible patients to help lower out-of-pocket costs so they can get access to NUCALA. Most insured patients are eligible for coverage for NUCALA. However, coverage can vary by plan type and is dependent on medical necessity requirements.

 

Acquisition

NUCALA is available through a variety of options, including specialty distributors, wholesalers, and our network of specialty pharmacies.

 

Reimbursement

Use Gateway to NUCALA for key reimbursement support such as coding requirements and appeals research in the event of a claim denial.

 

GETTING STARTED
ONGOING SUPPORT
Benefit verification with:
Patients can count on:
 Summary of coverage
 Prior authorization information and next-step instructions
 Cost-sharing information
 Coding and billing information
 Specialty pharmacy triage, if applicable
 Live support call-center assistance
 Coverage and cost-sharing information
 Review of co-pay assistance and patient assistance programs as applicable
 Reverification for annual health plan changes
 Reauthorization reminders
 Ongoing coding, claims, and appeals support

Get started with enrollment today

Call 844-4-NUCALA (844-468-2252)
Monday through Friday, 8 AM to 8 PM ET

   830268R0 December 2017